First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2013-01-04 13:10:33Open Document File Size: 329,68 KBShare Result on FacebookCompanyParke-Davis / PLAN INC. / PFIZER INC. / Two Marketing Partnerships / Aetna Inc. / Warner-Lambert / Guardian Life Insurance Company / Warner-Lambert Company / Kaiser / /CountryUnited States / /CurrencyUSD / /EventJudicial Event / FDA Phase / /FacilitySouthern California Pharmacy / /IndustryTermdirect communications / advertising supplements / medical insurance / treatment for epilepsy / Epilepsy Treatment / snake oil / treatment of bipolar disorder / pharmaceutical / non-profit healthcare / /MedicalConditionPost-Herpetic Neuralgia / Migraine / Pain / injury / epilepsy / G. Injury / Bipolar Disorder / /OrganizationFood and Drug Administration / Southern California Pharmacy and Therapeutics Committee / UN Court / Therapeutics Committee / FDA / /PersonMathew Trial / Van de Vusse / Tai Trial / H. Neurontin / /Positionchairperson / representative / U.S.D.J. / officer / /ProductNEURONTIN / Post-Herpetic Neuralgia / /ProvinceOrStateCalifornia / Massachusetts / /PublishedMediumthe Cochrane Review / /RegionSouthern California / /SocialTag |